|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhatla N, Berek JS, Fredes MC, Denny LA,
Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J,
et al: Revised FIGO staging for carcinoma of the cervix uteri. Int
J Gynaecol Obstet. 145:129–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chino J, Annunziata CM, Beriwal S,
Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM,
Holschneider CH, Kamrava M, et al: Radiation therapy for cervical
cancer: Executive summary of an ASTRO clinical practice guideline.
Pract Radiat Oncol. 10:220–234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lukas J, Lukas C and Bartek J: Mammalian
cell cycle checkpoints: Signalling pathways and their organization
in space and time. DNA Repair (Amst). 3:997–1007. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao Y, Li Z, Sheng W, Miao J and Yang J:
Radiosensitivity by ING4-IL-24 bicistronic adenovirus-mediated gene
cotransfer on human breast cancer cells. Cancer Gene Ther.
20:38–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang X, Zhang QL, Tian YH, Huang JC and
Ma GL: RNA interference-mediated gene silencing of cyclophilin A
enhances the radiosensitivity of PAa human lung adenocarcinoma
cells in vitro. Oncol Lett. 13:1619–1624. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Yu L, Wang Y, Zhang Y, Wang Y and
Zhang G: Expression of tumor suppressor gene ING4 in ovarian
carcinoma is correlated with microvessel density. J Cancer Res Clin
Oncol. 138:647–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gunduz M, Nagatsuka H, Demircan K, Gunduz
E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K,
Beder L, et al: Frequent deletion and down-regulation of ING4, a
candidate tumor suppressor gene at 12p13, in head and neck squamous
cell carcinomas. Gene. 356:109–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coles AH and Jones SN: The ING gene family
in the regulation of cell growth and tumorigenesis. J Cell Physiol.
218:45–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu M, Xie Y, Sheng W, Miao J and Yang J:
Adenovirus-mediated ING4 gene transfer in osteosarcoma suppresses
tumor growth via induction of apoptosis and inhibition of tumor
angiogenesis. Technol Cancer Res Treat. 14:369–378. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan R, He L, Li Z, Han X, Liang J, Si W,
Chen Z, Li L, Xie G, Li W, et al: SCF(JFK) is a bona fide E3 ligase
for ING4 and a potent promoter of the angiogenesis and metastasis
of breast cancer. Genes Dev. 29:672–685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weichselbaum RR and Kufe D: Translation of
the radio- and chemo-inducible TNFerade vector to the treatment of
human cancers. Cancer Gene Ther. 16:609–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kufe D and Weichselbaum R: Radiation
therapy: Activation for gene transcription and the development of
genetic radiotherapy-therapeutic strategies in oncology. Cancer
Biol Ther. 2:326–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond
HP and Wang JH: Combined IFN-gamma-endostatin gene therapy and
radiotherapy attenuates primary breast tumor growth and lung
metastases via enhanced CTL and NK cell activation and attenuated
tumor angiogenesis in a murine model. Ann Surg Oncol. 16:1403–1411.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W and Li XY: Anti-tumor effect of
pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing
Lewis lung carcinoma and its mechanism. Chin Med J (Engl).
118:296–301. 2005.PubMed/NCBI
|
|
16
|
Arai M, Kawachi T, Setiawan A and
Kobayashi M: Hypoxia-selective growth inhibition of cancer cells by
furospinosulin-1, a furanosesterterpene isolated from an Indonesian
marine sponge. ChemMedChem. 5:1919–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toma-Daşu I, Daşu A and Karlsson M: The
relationship between temporal variation of hypoxia, polarographic
measurements and predictions of tumour response to radiation. Phys
Med Biol. 49:4463–4475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hickey MM and Simon MC: Regulation of
angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev
Biol. 76:217–257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leskov KS, Criswell T, Antonio S, Li J,
Yang CR, Kinsella TJ and Boothman DA: When X-ray-inducible proteins
meet DNA double strand break repair. Semin Radiat Oncol.
11:352–372. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rovetta F, Stacchiotti A, Faggi F,
Catalani S, Apostoli P, Fanzani A and Aleo MF: Cobalt triggers
necrotic cell death and atrophy in skeletal C2C12 myotubes. Toxicol
Appl Pharmacol. 271:196–205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rockwell S, Dobrucki IT, Kim EY, Marrison
ST and Vu VT: Hypoxia and radiation therapy: Past history, ongoing
research, and future promise. Curr Mol Med. 9:442–458. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moeller BJ and Dewhirst MW: HIF-1 and
tumour radiosensitivity. Br J Cancer. 95((1)): 1–5. 2006.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaanders JH, Bussink J and van der Kogel
AJ: ARCON: A novel biology-based approach in radiotherapy. Lancet
Oncol. 3:728–737. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Xie Y, Sheng W, Miao J, Xiang J and
Yang J: Tumor-suppressive effect of adenovirus-mediated inhibitor
of growth 4 gene transfer in breast carcinoma cells in vitro and in
vivo. Cancer Biother Radiopharm. 25:427–437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du Y, Cheng Y and Su G: The essential role
of tumor suppressor gene ING4 in various human cancers and
non-neoplastic disorders. Biosci Rep. 39:BSR201807732019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie Y, Zhang H, Sheng W, Xiang J, Ye Z and
Yang J: Adenovirus-mediated ING4 expression suppresses lung
carcinoma cell growth via induction of cell cycle alteration and
apoptosis and inhibition of tumor invasion and angiogenesis. Cancer
Lett. 271:105–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You Q, Wang XS, Fu SB and Jin XM:
Downregulated expression of inhibitor of growth 4 (ING4) in
advanced colorectal cancers: A non-randomized experimental study.
Pathol Oncol Res. 17:473–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang QS, Li M, Zhang LY, Jin Y, Tong DD,
Yu Y, Bai J, Huang Q, Liu FL, Liu A, et al: Down-regulation of ING4
is associated with initiation and progression of lung cancer.
Histopathology. 57:271–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Galal El-Shemi A, Mohammed Ashshi A, Oh E,
Jung BK, Basalamah M, Alsaegh A and Yun CO: Efficacy of combining
ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy:
First evidence in preclinical hepatocellular carcinoma. Gene Ther.
25:54–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang H, Zhou X, Xu C, Yang J, Xiang J,
Tao M and Xie Y: Synergistic tumor suppression by
adenovirus-mediated ING4/PTEN double gene therapy for gastric
cancer. Cancer Gene Ther. 23:13–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Yang J, Sheng W, Xie Y and Liu J:
Adenovirus-mediated ING4/PTEN double tumor suppressor gene
co-transfer modified by RGD enhances antitumor activity in human
nasopharyngeal carcinoma cells. Int J Oncol. 46:1295–1303. 2015.
View Article : Google Scholar : PubMed/NCBI
|
